APA (7th ed.) Citation

Aguilera-Correa, J., Sánchez-Niño, M. D., Ortiz, A., Sáez Martínez, E. F., Martínez-Cuesta, M. C., Peláez, C., . . . Requena, T. (2019). Effect of lyso-Gb3 on the intestinal microbiota may contribute to gastrointestinal symptoms in Fabry’s disease patients.

Chicago Style (17th ed.) Citation

Aguilera-Correa, John-Jairo, María Dolores Sánchez-Niño, Alberto Ortiz, E. F. Sáez Martínez, M. Carmen Martínez-Cuesta, Carmen Peláez, Jaime Esteban, and Teresa Requena. Effect of Lyso-Gb3 on the Intestinal Microbiota May Contribute to Gastrointestinal Symptoms in Fabry’s Disease Patients. 2019.

MLA (8th ed.) Citation

Aguilera-Correa, John-Jairo, et al. Effect of Lyso-Gb3 on the Intestinal Microbiota May Contribute to Gastrointestinal Symptoms in Fabry’s Disease Patients. 2019.

IICA/CATIE Citation

Aguilera-Correa, J., Sánchez-Niño, M. D., Ortiz, A., Sáez Martínez, E. F., Martínez-Cuesta, M. C., Peláez, C., . . . Requena, T. 2019. Effect of lyso-Gb3 on the intestinal microbiota may contribute to gastrointestinal symptoms in Fabry’s disease patients.